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Chapter 1 
Introduction – Kinds of Children 
 
Ayo Wahlberg & Tine M. Gammeltoft 
 
    This book is about selective reproduction in the 21st century. Although selective reproductive 
practices have existed for a long time (Gammeltoft & Wahlberg 2014), 21st century biomedicine 
provides historically unprecedented possibilities for technological interventions in childbearing 
processes. In the past forty years, human reproduction has been technologically parcelled out 
into specialised fields of insemination, fertilisation, implantation, gestation, termination and 
(preterm) birth. Such developments have separated reproduction from sex as well as genetics 
from gestation. As such, in the 21st century, selective reproduction increasingly takes place 
through decisions about which gametes to fertilise, which embryos to implant, or which foetuses 
to abort. These new possibilities for decision-making and choice raise urgent questions for social 
scientists. 
    In this volume, we use the term selective reproduction to refer to practices that aim to prevent 
or promote the birth of particular kinds of children. What we collectively show in the following 
chapters is how selective reproductive technologies (SRTs) have been developed and routinized 
– which is to say taken up, practiced, and experienced – around the world over the last few 
decades. Selective reproduction is ubiquitous and not limited to any specific parts of the world, 
although the ways in which SRTs gain traction and stabilise are multiple. With the increasing 
availability of SRTs, selective reproduction is taking place on a historically unprecedented scale; 
through sex-selective abortion following ultrasound scans, abortion following detection of foetal 
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anomalies during routinized prenatal screening and testing programmes, the development of 
preimplantation genetic diagnosis techniques as well as the screening of potential gamete donors 
by egg agencies and sperm banks (see Table 1).1 
 
From ‘helping hand’ to ‘guiding hand’ 
 
    Over the last three decades or so, social scientists have followed assisted reproductive 
technologies (ARTs) on routes of routinization and globalization, examining their development 
by clinicians and scientists as well as their impact on the daily lives of involuntarily childless 
couples in different cultural and socio-economic settings. Indeed, Marilyn Strathern’s reflections 
on such reproductive technologies as ‘nature assisted’ have provided an entire generation of 
social scientists with conceptual tools for analysing supposed nature-artifice divides in the field 
of human reproduction as well as for troubling separations of the natural from the social. “Nature 
assisted”, as she wrote in Reproducing the Future, “compromises the definition of nature as 
those conditions of life from which intervention is absent; what is given is no longer given by 
nature itself but is visibly circumscribed by technological capacity” (1992: 57). Writing in the 
early years of reproductive technologies, Strathern was referring mostly to ARTs: “artificial 
insemination, in-vitro fertilisation, or other practices such as GIFT (gamete intra-fallopian 
transfer) simply stand in, so the justification goes, for natural body processes” (Strathern 1998: 
186). “If nature can’t deliver” as one medical company put it in early 1990s marketing material, 
then “nature sometimes needs a helping hand” (Strathern 1992: 56, 57). 
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Major forms of selective reproduction in the 21st century 
 
Objective of selection 
  
Type of selection (SRT) Scope 
Selecting for desired sex 
(sex selection) 
• Sex selective abortion following prenatal 
determination of foetal sex 
• Sex selective implantation of embryos 
following in vitro fertilization (IVF) and 
embryo biopsy (PGD) 
• Sex selective fertilization of gametes 
following the MicroSorting® of sperm 
cells in a semen sample based on the 
chromosome they are carrying (can only 
influence sex of embryo) 
 
Sex selective abortion is legally prohibited in most 
countries of the world. Nevertheless, millions of 
especially female foetuses are aborted annually 
around the world. In countries like China, India and 
Vietnam, obstetric ultrasound has contributed to 
unprecedented sex ratios at birth as high as 120 boys 
for every 100 girls. While sex selective abortion is 
often considered to be a problem of the so-called 
global South linked to son preference, sex selective 
fertilization of gametes or implantation of embryos 
(as opposed to abortion) is often described as “family 
balancing” or “lifestyle” sex selection in the global 
North. While prohibited in some countries, thousands 
of cycles of MicroSort® insemination and PGD for sex 
selective purposes are carried out each year globally. 
Selecting for a 
healthy/normal child 
(prevention of disease/disability) 
 
• Selective abortion of foetuses following 
detection of “serious” fetal abnormality, 
chromosomal disorder or genetic disease 
• Selective implantation of only 
unaffected/healthy embryos following in 
vitro fertilization (IVF) and embryo 
biopsy (PGD) 
• Sex selective fertilization of gametes 
following the MicroSorting® of sperm 
cells in a semen sample based on the 
chromosome they are carrying (can only 
influence sex of embryo) in order to 
avoid transmitting a sex-linked genetic 
disease 
• Selective fertilization of gametes 
following medical screening of gamete 
donors to prevent transmission of 
infectious or genetic disease 
 
Prenatal screening programmes have been routinized 
throughout the world covering millions of women 
(there are an estimated 213 million pregnancies 
globally every year, not all are screened) involving 
combinations of maternal serum screening, free foetal 
DNA screening, obstetric ultrasound scans and 
invasive prenatal diagnosis. Legislation varies with 
some countries allowing for late-term abortions if a 
“serious” condition is detected. Such terminations 
remain controversial in many countries and there is 
no consensus as to what conditions (if any) are 
considered serious enough to warrant an abortion. 
Following the detection of foetal abnormalities, 
chromosomal disorders or genetic 
diseases/conditions, hundreds of thousands of 
pregnancies are terminated annually (legally and 
illegally) around the world (there are an estimated 45 
million induced abortions globally every year, we 
estimate between 0.2-1% of abortions are on grounds 
of substantial risk that the child would be seriously 
affected if the pregnancy is not terminated). 
Thousands of cycles of MicroSort® insemination 
and/or PGD are carried out around the world to 
prevent transmission of a genetic disease. 
Selecting for desired traits 
(donor selection) 
• Selective fertilization of gametes 
following the choosing of a suitable 
gamete donor based on available 
information about donor health, eye 
colour, hair colour, blood type, height, 
intelligence, beauty, race/ethnicity, etc. 
• Selective implantation of embryos with 
disabilities by parents with disabilities 
(e.g. deafness or dwarfism)  
 
Sperm banks and egg brokers screen thousands of 
potential gamete donors every year. Of these, 
between 10-20% are selected as qualified donors 
according to screening criteria. Legislation varies with 
some countries prohibiting all gamete donation and 
others allowing infertile couples, single women and/or 
lesbian and gay couples to access donor gametes. 
Studies have shown that infertile heterosexual 
couples are mostly concerned with health and less 
concerned with traits while gay couples, lesbian 
couples and single women often select for traits that 
are familiar to them and their families. Hundreds of 
thousands of donor babies have been born 
worldwide, the first major cohort of which (born in 
the 1980s) is now actively seeking out donor siblings 
and their biological fathers or mothers. 
Selecting for saviour siblings 
(HLA matching) 
• Selective implantation of histologically 
compatible embryos following in vitro 
fertilization, embryo biopsy and HLA 
(human leukocyte antigen) typing (using 
PGD) in order to treat a sick sibling 
 
Hundreds of saviour siblings have been created using 
PGD throughout the world starting in the United 
States of America in 2000. Using PGD to create saviour 
siblings remains controversial (because of concerns 
about the welfare and instrumentalisation of the 
saviour child) and not all countries allow it. 
Table 0.1: Major forms of selective reproduction in the 21st century (see References for sources) 
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    Such technologies have become routine throughout the world, to an extent that the birth of the 
world’s 5 millionth IVF baby was celebrated by the European Society of Human Reproduction 
and Embryology in July 2012. A string of ethnographies over the last two decades have shown 
how IVF is construed as a solution to the disruptions of infertility and can become a way of a life 
for many involuntarily childless couples as treatment appointments, drug regimens, oocyte 
retrievals and embryo transfers take over their daily lives with many couples opting for multiple 
cycles in the face of repeated failure (Franklin 1997; Becker 2000; Thompson 2005). We have 
also seen how the development and practice of ART comes to be shaped by local moralities as 
well as national aspirations and programmes in so-called pro-natalist countries like Egypt, Israel, 
India and China (Inhorn 2003; Kahn 2000; Handwerker 2002; Bharadwaj 2016; Wahlberg 2016). 
Finally, as couples are increasingly prepared to travel in pursuit of conception, social scientists 
have turned their attention towards the phenomenon of ‘reproductive tourism’ or ‘reproductive 
travel’ as involuntarily childless couples – ‘reproductive exiles’ – cross international borders as a 
way to circumvent local restrictions, seek better quality care or more affordable treatment 
(Inhorn & Gürtin 2011; Inhorn 2015; Stockey-Bridge, this volume). 
    In recent years, similar ethnographic attention has been directed at what we term selective 
reproductive technologies (SRTs) (Gammeltoft & Wahlberg 2014). It is important to distinguish 
between ARTs and SRTs, not least because of the differing objectives that are at stake. If ‘nature 
assisted’ is a fitting caption for ARTs, then SRTs might be summarized as ‘nature directed’. This 
is what Sarah Franklin and Celia Roberts were pointing to when contrasting IVF and 
preimplantation genetic diagnosis (PGD) in Born and Made. While both involve in vitro 
fertilisation, “the goal of IVF is a child, whereas the goal of PGD is, in a sense, the reverse, in 
that it is aimed at preventing some kinds of children being born” (Franklin & Roberts 2006: 
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161).2 The point being that, SRTs involve a decision not just to seek a viable pregnancy and a 
birth, but indeed to determine pregnancy outcome in very specific ways, which is to say by 
preventing or promoting the birth of specific kinds of children. Indeed SRTs can be thought of as 
a vote of no confidence against nature, as they do not so much stand in for natural biological 
processes as they seek to steer or obstruct these same processes. Social studies of ARTs have 
pointed to the importance of kinship and relatedness in explaining the uptake of such 
technologies as involuntarily childless couples go to great lengths to ensure that they have their 
own, genetically related children (Edwards et al. 1993). SRTs on the other hand, are not 
primarily playing out in a context of infertility. Couples who pursue the use of SRTs are 
typically not negotiating an inability to conceive and as a result are not primarily concerned with 
ensuring succession through genetically related offspring or realising a dream of having a family. 
Instead they orient themselves towards the future living of their families. When making selective 
reproductive decisions, families invariably engage with their futures in terms of different kinds 
of living that they might wish to avoid (e.g. living with cystic fibrosis or living ‘only’ with girls) 
or achieve (e.g. living with healthy children, raising a son) (see Wahlberg 2009). In these cases it 
is not that nature can’t deliver, it is rather that nature cannot be left to its own devices. 
    Having distinguished between the two, we know of course that any proposed dividing line 
between ARTs and SRTs will always be blurred not least since techniques often overlap and 
since it is difficult to imagine any reproductive process devoid of attempts to influence 
pregnancy outcomes. We see this in the case of transnational surrogacy involving egg donors 
(see Stockey-Bridge, this volume) or in the IVF clinics which now attract both couples seeking 
to overcome infertility and couples seeking to prevent transmission of a hereditary disease 
through embryo biopsies and PGD (see Pavone & Lafuente, this volume). Nevertheless, it is, as 
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this book shows, analytically productive to distinguish between what might be thought of as two 
different reproductive schemas, namely ‘helping hand’ or assisted reproduction which aims to 
technologically overcome biological obstacles to reproduction on the one hand, and ‘guiding 
hand’ or selective reproduction which aims to technologically prevent or promote the birth of 
certain kinds of children on the other, that is to say between nature assisted and nature directed. 
 
Gametes, embryos, fetuses 
 
    As we have already pointed out, selective reproduction is nothing new. But if we look at this 
reproductive schema today, we can see how, until only relatively recently, selective reproduction 
mainly took place at the two poles: either before fertilization (think of partner selection or 
sterilization) or following birth (think of infanticide or selective neglect). We say mainly because 
pregnancy of course has been subject to all kinds of taboos and advices aimed at generically or 
specifically influencing pregnancy outcomes for a very long time, just as induced abortion has 
been used to prevent transmission of traits to offspring. Nonetheless, it is fair to say that since the 
1970s, following the birth of Louise Brown, the development of increasingly sophisticated 
biomedical technologies has allowed for selective reproductive practices to become more 
targeted. Not only has human reproduction been separated from sex, as already noted, the entire 
reproductive process has been parcelled out and fragmented using ever more specialized 
techniques related to insemination, fertilization, implantation, gestation, and birth. Gamete banks, 
medical/clinical genetics departments, IVF laboratories, prenatal clinics, abortion clinics, 
neonatal units and maternity wards are each involved in reproductive health care in different 
ways. Moreover, with the advent of cryopreservation in the latter half of the 20th century, each 
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reproductive segment can be realized in different places (indeed on opposite sides of the world), 
using gametes from partners and/or donors (at times in combination with gestational surrogates) 
and at varied intervals (the record with frozen sperm is 25 years and legal requests for 
posthumous use of frozen gametes or embryos are increasing around the world). Reproduction, it 
is safe to say, has become transbiological, transtemporal and transnational in hitherto unimagined 
ways while introducing possibilities of selection at each step. 
    At the same time, this fragmentation of the reproductive process has introduced new 
reproductive sites, techniques, forms of expertise and dilemmas. SRTs comprise of specific 
laboratory and clinical techniques which facilitate the selective fertilisation of gametes, 
implantation of embryos or abortion of foetuses (see Box 1). Decisions about which gametes to 
fertilise, which embryos to implant or which foetuses to abort are explicitly wound up in ideas 
about the kinds of children that are desired or unwanted; ideas which in turn are inextricably 
bound to the kinds of societies within which selective reproduction is taking place. Prospective 
parents who engage with SRTs are not dealing with ways to overcome involuntary childlessness, 
rather they are involved in the planning of future family life. 
    In countries where gamete donation is allowed, sperm banks and egg agencies make selective 
decisions about which donors to accept by socially and medically screening them. Such 
screening practices are shaped by cultural values and social norms around notions of what a 
‘high quality’ or ‘good quality’ donor might be, often times reifying eugenicist notions of 
positive selection (see Martin, this volume). These values and norms not only shape their 
recruitment and screening practices, they are also actively mobilised in marketing campaigns and 
information provided to prospective parents which include infertile couples, single women and 
lesbian couples (albeit with differential access in different countries depending on legislation) 
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(see Stockey-Bridge, this volume). Moreover, couples with a known sex-linked genetic disease 
in their family may choose to Microsort® their sperm prior to insemination or in vitro 
fertilisation as a means of sex selecting in order to avoid transmitting that disease. Microsort® 
has also been marketed as a potential means for sex selective ‘family balancing’ (see Bhatia, this 
volume). In selectively deciding which gametes to use, prospective parents are confronted with 
questions about which kinds of children are desired or unwanted for them as they go about 
planning their future family lives. 
    One of the consequences of routinized infertility treatment has been the bioavailability of 
embryos in vitro (cf. Cohen 2007). While these human embryos were initially produced in the 
clinic to identify those embryos considered to be the most viable for infertile couples seeking to 
achieve pregnancy, since 1990, increasing numbers of couples have chosen to pursue IVF cycles 
in order to allow embryologists to biopsy resulting embryos. Such biopsies provide geneticists 
with access to a potential child’s DNA, allowing for genetic testing prior to implantation, which 
is known as preimplantation genetic diagnosis (PGD). PGD was developed to help families with 
a known hereditary disease to avoid commencing an affected pregnancy, thereby hopefully 
alleviating them of the difficult decision of whether or not to terminate a pregnancy. As such, 
PGD is a form of family planning that has become an option for some so-called carriers of a 
genetic mutation who want to avoid passing on a disease that lies dormant in their genes. More 
recently, PGD has also been used as a means to secure the birth of a histologically compatible 
child (a so-called saviour sibling) who can provide blood and tissue samples for therapeutic use 
in a sick sibling suffering from, for example, sickle cell anaemia or β-thalassaemia (Dobson 
2003). Finally, PGD has emerged as a technique to facilitate ‘lifestyle’ sex selection or ‘family 
balancing’ for some couples. And so, just like in the case of gamete sorting, couples who  
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Four important milestones in the development of SRTs globally 
 
Seeing the foetus – ever since ultrasound technology was first used for foetal head measurements in the 1960s, its ability 
to detect gender and physical abnormalities has propelled it to universal use in prenatal care. Sex selection is by far the 
most common form of selective reproduction today and the correlation between growing ultrasound availability and 
the skewing of sex-ratios in countries like China, India and Vietnam is dramatic (UNFPA 2012). Moreover, foetal 
anomaly scans halfway through a pregnancy have become routine throughout the world to detect and confirm 
diagnoses of anencephaly, spina bifida, Edward’s syndrome and more, generating dilemmas for parents as they consider 
whether to continue or terminate a pregnancy. 
 
Decoding the foetus – the development of reproductive genetics has had a profound effect on antenatal care. While 
ultrasound technologies are becoming ever better at seeing the foetus they cannot tell parents anything about their 
foetus’s genetic makeup which is hidden away in its DNA. As such, ever since Fuchs and Riis in 1956 reported being 
able to determine the sex of a foetus after having collected amniotic fluid from pregnant women (Fuchs & Riis 1956), 
clinicians have been looking for safe and reliable ways of getting access to a foetus’s DNA. Amniocentesis, chorionic 
villus sampling and most recently free foetal DNA testing have each been developed for this purpose and have 
become standard offers for women during antenatal care. Once samples of a foetus’s DNA are available, they can be 
subject to a battery of genetic tests and screens to determine whether the foetus has a rare genetic disease, Down’s 
syndrome or other chromosomal disorder. Concomitant screening procedures have also been developed to help 
identify those couples considered at risk who may then opt for an invasive procedure to get access to foetal DNA. 
Most recently, isolation of free foetal DNA from an expecting woman’s serum has made non-invasive prenatal testing a 
reality. 
 
Avoiding transmission – family disease history has long played a role in reproductive decision making as families have 
sought to avoid passing on debilitating conditions such as Huntington’s disease or aggressive forms of cancer to their 
children. In the post-World War II period, genetic counselling emerged as a particular specialisation in hospitals 
aimed at providing couples with a known (or suspected) hereditary disease with information about how inheritance 
works and what options they have when planning a pregnancy. Options may include carrier testing to see whether the 
man, woman or both carry a mutation of a genetic disease followed by gamete donation, preimplantation genetic 
diagnosis (PGD) of embryos or prenatal genetic testing of foetuses. Genetic counsellors are trained to be ‘non-
directive’ as they encourage couples to make their own decisions about whether to begin, continue or terminate a 
pregnancy. 
 
Sorting gametes and embryos – one of the important consequences of IVF technology has been displacement of the 
fertilisation process from the womb to the laboratory. No longer only brought together through sexual intercourse, 
gametes can now be retrieved after which they can be prepared, sorted, cryopreserved and eventually fertilised. Once 
fertilised, clinicians are faced with the decision of which resulting embryos (and how many) to implant into the woman. 
A number of selective practices have emerged in the lab as a result, each of which is used to prevent or promote the 
birth of certain kinds of children. Developed in the 1970s, Microsorting® ‘separates the sperm cells in a semen sample 
based on the chromosome they are carrying… result[ing] in samples containing significantly increased percentages of 
sperm that are carrying the desired (X or Y) chromosome’ (MicroSort 2013). In this way, couples can significantly 
increase their chances of conceiving a boy or a girl or avoid transmitting a sex-linked genetic disease by inseminating 
sorted sperm or by using sorted sperm in conjunction with IVF. Similarly, gamete banks and brokers tend to select 
‘good quality’ donor candidates with traits considered desirable by recipients. Since 1990, preimplantation genetic 
diagnosis (PGD) clinics have carried out genetic tests on successfully fertilised embryos by taking a cell biopsy from 
each embryo as a way to decide: which affected (or mutation carrying) embryos should not be implanted in order to 
avoid transmission of hereditary disease; which histologically compatible embryos should be chosen for implantation to 
produce a so-called saviour sibling; or which embryo should be chosen for implantation to secure the birth of a boy or 
a girl. 
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Box 1 
selectively decide which embryos to implant following embryo biopsies and genetic tests are 
confronted with questions about which kinds of children are desired (e.g. a girl or an HLA-match 
for a sick sibling) or unwanted (e.g. a child with cystic fibrosis or Huntington’s disease) as they 
attend to their current families while imagining their future family lives. 
    Throughout the world, pregnancies have come to be the object of various forms of medicalised 
surveillance through routine prenatal care which can involve ultrasound scans, maternal serum 
tests as well as amniocentesis or chorionic villus sampling. The goal of this surveillance is to 
monitor the health of women and foetuses during gestation as a way to ensure safe and healthy 
births. With the global routinization of ultrasound scans as well as prenatal risk assessments in 
the closing decades of the 20th century, one can say that the majority of pregnancies have become 
potentially selective – or ‘tentative’ in Barbara Rothman’s (1993) phrase – as prospective parents 
grapple with societal expectations and their own convictions about which kinds of children are 
desired (e.g. a son) or unwanted (e.g. a child with Down’s Syndrome) as they prepare for an 
approaching birth. Termination of pregnancy – whether for sex selective reasons (millions of 
pregnancies have been estimated to have been terminated to avoid the birth of a girl) or to 
prevent the birth of a child with a serious disease (thousands of pregnancies are terminated 
around the world each year following prenatal screening, testing and diagnosis) – is the most 
ubiquitous form of selective reproduction in the 21st century. The surveillance and, in some cases, 
ensuing terminations of pregnancies are, existing research shows, often shrouded in deep 
ambivalence, as pregnant women, relatives, and health care providers agonize over the – 
potential or actual – life-and-death decisions that SRTs confront them with (see Rapp 1999, 
Gammeltoft 2014, Trần, this volume). 
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Tracking routes of routinization 
 
    Any attempt to empirically address the unfolding routinization of SRTs globally, as this book 
sets out to do, must attend to a multitude of problematics. As medical technologies, SRTs must 
traverse the continuum from experimental technology to standard of care to become routinized 
(Koenig 1988), a process that is unique to every country. SRTs have tended to go through 
variegated patterns of acceptance in different countries: from pioneering ‘breakthroughs’, at 
times followed by periods of concern and resistance, then regulation and eventually routinization 
as particular procedures are rolled out and made available (Wahlberg 2016). Consequently, we 
propose four important empirical routes to studying SRTs in the 21st century. First of all, as we 
have seen, there are a range of techniques. SRTs comprise a plethora of specialized techniques – 
such as amniocentesis, ultrasound scans, sperm sorting, preimplantation genetic diagnosis and 
carrier testing – each of which zooms in on a particular segment of the reproductive process. 
Each technique can be (and indeed have been by many scholars) studied in terms of its history, 
social life and/or social impact (Rapp 2000; Franklin & Roberts 2006; Gammeltoft 2014). Once 
standardized, such techniques can be rolled out in the form of routine prenatal care or national 
screening programmes. Among the techniques that will be explored in the following chapters are 
sperm-sorting, egg harvesting, preimplantation genetic diagnosis, maternal serum screening and 
ultrasound screening. 
    Secondly, as noted earlier, one of the consequences of the fragmentation of the reproductive 
process has been the emergence of specialised sites dealing with particular aspects of 
reproduction. It is in these sites that we as social scientists often must negotiate access and carry 
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out our fieldwork and interviews, ranging from sperm banks to clinical genetics units, IVF labs, 
prenatal clinics, abortion clinics and labour wards, not to mention the homes and communities of 
all those couples who engage with SRTs. To understand routinization we need to visit the places 
in which certain diagnostic and screening offers operate on a daily basis, witnessing the daily 
grind while analysing the interactions between professionals, techniques and couples. 
Contributors to this volume have carried out research in egg agencies, IVF clinics, prenatal care 
units, ultrasound clinics as well as pregnancy termination units. 
    Thirdly, it is arguably the people that engage with SRTs that are the most important 
constituents in understanding how SRTs come to be routinized and globally widespread. The 
field of selective reproductive technologies is filled with a myriad of choreographies, decision-
making processes, evaluations and deliberations. In researching SRTs we meet its users in the 
form of ‘prospective parents’, ‘intending parents’, ‘expecting couples’, ‘pregnant women’ or 
‘families’ who at times will choose to use a gamete donor or surrogate mother. To understand 
how SRTs are experienced and incorporated into individual family planning strategies – whether 
in accordance or in conflict with dominant cultural values and social norms – it is essential that 
social scientists spend time with those who make use of SRTs. We also meet SRT practitioners 
such as clinicians, nurses, geneticists, sonographers, midwives, gamete brokers, gynaecologists, 
obstetricians, nurses and embryologists who go about ensuring that SRT services are provided to 
users, often in so-called resource poor settings. Perhaps inevitably, considering the controversies 
that surround selective reproduction, social scientists also often seek out policymakers, 
government officials, lawyers and ethicists in their countries of study as part of their efforts to 
understand how SRTs are normalized in particular places and at particular historical moments. It 
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is these users, practitioners and regulation makers that each of us has talked to and spent time 
with when studying selective reproduction in the 21st century in different parts of the world. 
    Finally, empirical engagement with SRTs will almost always lead not only to regulation 
makers but also to the laws, regulations and guidelines (as documents) which circumscribe the 
availability and intended use of SRTs. Selective reproduction is an ethically and emotionally 
charged field of practice governed not only by national laws such as the Embryo Protection law 
in Germany or the Law on Maternal and Infant Healthcare in China, but also by a host of 
procedures, guidelines, codes, contracts, forms, etc. aimed at ensuring acceptable (‘appropriate’ 
and ‘lawful’) use of SRTs in clinical settings through Good Clinical Practices, Good Laboratory 
Practices as well as ethical guidelines. Moreover, nation states invest heavily in the deployment 
of SRTs through screening programmes and health delivery systems, not least with the 
controversial (at times explicit, at others implicit) aim of reducing congenital malformations and 
hereditary disease. It is therefore virtually impossible, as we will see, to study SRTs today 
without familiarizing if not immersing ourselves into such regulatory debates and texts. 
    Taken together, these techniques, sites, people and regulations form selective reproductive 
assemblages, infrastructures or complexes (cf. Collier & Ong 2007; Inhorn 2015; Larkin 2013; 
Vertommen 2016; Wahlberg 2016) which are always particular to the different countries, 
economies, cultures and societies within which we study SRTs. As Wahlberg (2016) has argued, 
when it comes to medical technologies, routinization is a socio-historical process whereby 
certain forms of medical technology come to be (re-)produced and entrenched within particular 
juridical, medical, social, economic, cultural and institutional configurations. It also entails a 
daily grind of practices through which certain medical technologies are rolled out and become an 
established and habituated part of health delivery, which is to say a standard of care provided in a 
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fixed setting. And finally, routinization suggests a gradual take up and acceptance of a medical 
technology such that it becomes a normalised part of daily life, in the sense that it is available to 
and used by its intended users in a routine manner, albeit surrounded by all manner of socio-
economic or cultural barriers. In the chapters that follow, we will learn how SRTs came to be 
routinized in different parts of the world from Denmark to Spain, Vietnam, India, Taiwan, 
Australia and USA. 
 
Tracking the economic and political forces underpinning routinization 
 
    Across the globe, SRTs are located at a convergence of political and economic forces. In some 
countries, national governments define SRTs as political tools, mobilizing new technologies for 
selective reproduction in overt efforts to enhance “population quality” (see Shih, this volume). 
Seeking to prevent the birth of children with disabilities, the governments of China and Vietnam 
for instance are actively encouraging pregnant women to make use of prenatal screening and 
testing technologies. A strong and healthy population, government authorities inform people, is a 
precondition for national stability and welfare (Zhu 2013; Greenhalgh & Winckler 2005; 
Gammeltoft 2014). In other countries, most notably in Europe and the US, the spectre of 20th 
century eugenics continues to haunt present-day reproductive policies, compelling state 
authorities to frame selective reproductive decisions as matters of personal preference and choice 
rather than as matters of demography. SRTs are not, government documents emphasize, 
introduced to serve demographic purposes; rather, they serve as medical means by which citizens’ 
capacities to make their own reproductive choices can be enhanced (Schwennesen & Koch 2009; 
Meskus 2009). As much research has shown, however, individual reproductive choices are 
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always formed by the socio-political contexts within which they are made, guided by powerful 
societal norms, values, and expectations (see Heinsen, this volume; Shih, this volume; Trần, this 
volume; Rapp 1999). This is the case also in social settings where official health care practice 
guidelines emphasize balanced information and individual choice: such information provision 
tends to be carried by particular normative demands and expectations, pushing people in certain 
decision-making directions. Consequently, some critics have characterized 21st century selective 
reproduction as a ‘laissez-faire,’ ‘back-door,’ ‘neo,’ or ‘flexible’ eugenics (Duster 2003; Taussig 
et al. 2003; Lock 2007).  
    Besides political forces, economic forces also drive the introduction and routinization of SRTs. 
Within public health care systems, the introduction of state-funded programs for pregnancy 
screening and testing are often based on cost-benefit calculations assessing the costs saved if 
fewer children are born with disabilities (Schwennesen et al 2009). Some countries offer couples 
access to publicly funded carrier testing and, if a genetic disposition is found, access to publicly 
funded PGD. Yet these offers cover only certain selected conditions, and decisions regarding 
which prospective parents should be offered access to these technologies rely on calculations 
assessing the economic gains attained if the birth of a child with this particular condition is 
averted. The assumed societal resource implications are, in other words, often the subtle subtext 
when public sector SRTs are offered. Due to the sinister history of 19th century eugenics, 
however, such underlying economic rationales are often downplayed in official documents and 
policy guidelines, perhaps particularly in Europe where the eugenics movement had the most 
disastrous consequences (cf. Erikson 2003, Koch 2006). 
    When selective reproduction takes place in the private health care sector, economic rationales 
play important roles too. The parcelling out of reproductive processes described above has 
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entailed novel possibilities for commercialization and commodification: from being intimate and 
integral parts of individual bodies, human eggs and sperm have changed character and can now 
be extracted, stored, and circulated in national and transnational capitalist circuits. In the 
reproductive markets that this has generated, some gametes hold higher value than others, 
offering the prospect of considerable economic profit (e.g. Martin, this volume; Pavone & 
Lafuente, this volume; Almeling 2009; Pollock 2003). It is probably no coincidence that ‘sperm 
banks’ are described through metaphors derived from the financial world. As the bedrock of 
capitalism, banks facilitate markets, the notion of ‘sperm bank’ pointing us to the ways in which 
human bodies and their reproductive capacities are being turned into property in the 21st century. 
These processes are evident also in markets for babies. The increasing access to surrogacy 
services in countries around the world entails new possibilities for economic gain; cross-border 
surrogacy is by now a multi-billion dollar global industry (Deonandan 2015). As donor gamete 
selection is often involved in these arrangements, although surrogacy is primarily an assisted 
reproductive technology, it nonetheless can have its ‘selective moments’, as Stockey-Bridge 
shows us in Chapter 7. Further, in many countries with privatized health care systems, prenatal 
screening and testing are important sources of revenue for health care providers, and their 
economic interests may therefore fuel a technology’s routinization (cf. Gammeltoft and Nguyen 
2007). Selective reproduction is, in short, lucrative business in many respects, and as such a focal 
point of numerous economic interests. The biomedical research and technological development 
that precedes the launch of new SRTs will, as Bhatia’s (this volume) work in a Euro-American 
context exemplifies, often take place in an orientation towards a given technology’s 
marketability and economic potential. 
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    Economic calculations are, however, not restricted to the domains of states and markets; they 
are also made within domestic worlds. When individuals and couples resort to SRTs, personal 
assessments of the economic burdens and benefits that the birth of a particular kind of child will 
entail often contribute to shaping their motivations; users of SRTs are often engaged in active 
forms of planning or ‘reproductive accounting’ (Franklin and Roberts 2006: 164; Shih, this 
volume). In many cultures, a male child is expected to be of long-term economic gain to his 
parents, while a female child is considered as a cost (see Trần, this volume; Khanna 2010). The 
capacity to influence the sex of one’s children can therefore play an important role in domestic 
economic calculations, not least in low-income societies. Similarly, across the globe, prospective 
parents often express concern regarding the financial burdens that the birth of a disabled child 
can be expected to place on their household economy (Gammeltoft 2014; Kohrman 2005). Even 
in affluent welfare societies, parents-to-be must weigh the assumed needs of particular potential 
children against the care that they expect to be able to provide given the economic means they 
have at hand. Fears and anxieties regarding their own capacities to care adequately for their child 
often seem to push prospective parents towards the uptake of SRTs (Rapp 1999; Gammeltoft 201; 
Heinsen, this volume). As we will see in the chapters that follow, these various forms of 
reproductive accounting shape the ways in which SRTs come to be viewed, made available, and 
used in specific countries and settings. 
    Possibilities for SRT uptake are, however, unevenly distributed. While some technologies – 
such as 2D ultrasounds – are relatively low-cost and therefore generally accessible, access to 
other technologies, such as PGD, requires considerable economic means. Such uneven 
distributions are also evident in the moral separation of sex selective abortion (associated most 
often with countries of the global South) from PGD-enabled ‘lifestyle sex selection’ which is 
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marketed by IVF clinics in the US (cf. Trần, this volume & Bhatia, this volume). For most 
people in the contemporary world, access to SRTs is not a given. Economic stratification shapes 
not only people’s access to technology but also determines how they are positioned in relation to 
it: some individuals and couples are placed in economic positions that enhance their chances of 
realizing their reproductive desires, while others – such as women in low-income countries who 
carry other people’s children in their wombs in surrogacy arrangements – live in situations of 
economic vulnerability that expose them to considerable reproductive health risks. 
 
Conclusion: ethnographies of SRTs 
 
    The cultural, social and economic rationales that underlie the spread of SRTs have raised 
criticism from various quarters. Pointing to the alternative ways in which societal resources 
could be used, disability rights activists have argued that the promotion of SRTs tends to rest on 
and reinforce a reduction of the value of disabled lives. In Tom Shakespeare’s words: “The drive 
to use genetic and obstetric techniques to remove disabled people from the population fails to 
consider the millions of people developing impairments as a result of accident or disease during 
the life-course. Resources would be better spent on creating an inclusive and barrier-free society, 
and promoting the civil rights and independent living of disabled people. Society should value 
disabled people, alongside all human life” (1998: 678-79). In a similar vein, women’s health 
activists have criticised the subtle or not-so-subtle ways in which pregnant women are placed 
under pressure to conform to unspoken health systems expectations and opt for a pregnancy 
termination in case a child-to-be is found to be anomalous. Marsha Saxton, for instance, writes:  
“Those who advocate selective abortion to alleviate the suffering of children may often raise that 
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cornerstone of contemporary political rhetoric, cost benefit. Of course, cost-benefit analysis is 
not woman-centered, yet women can be directly pressured or subtly intimidated by both 
arguments. It may be difficult for some to resist the argument that it is their duty to ‘save scarce 
health care dollars,’ by eliminating expensive disabled children. But those who resist these 
arguments believe the value of a child’s life cannot be measured in dollars” (1998: 383; see also 
Lippman 1999). 
    Criticism has also been raised of the commercialization and manipulation of human 
childbearing that SRTs allow for. The concept of ‘designer baby’ captures ethical anxieties 
regarding what kind of society we are moving towards if increasing numbers of prospective 
parents are enabled to select for specific traits in their children, ‘buying’ the kinds of babies that 
they want. To date, however, such a brave new world of perfectly designed offspring still seems 
far away, as the contingencies involved in human childbearing appear to continue to surpass our 
capacities for technological manipulation (Franklin & Roberts 2006). 
    Against the backdrop of these important social and ethical debates, the task that we have set 
ourselves in this volume is empirical: What techniques have been developed to facilitate 
selective reproduction in recent decades? How are SRTs being rolled out and made available 
within different regulatory frameworks? How do people living in different cultural settings 
perceive, respond to, and make use of the new possibilities for selective reproduction that they 
are offered? Addressing the social and ethical questions that selective reproduction raises 
requires, we believe, concrete and critical insights into the ways in which new technologies for 
selective reproduction operate on the ground as people weave these technologies into family 
lives, clinical worlds, and political imaginaries. Through ethnographic studies conducted across 
the world, this volume seeks to provide such insights, thereby offering new and research-based 
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contributions to the ethical and political debates that selective reproduction will continue to 
generate in years to come. 
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Endnotes 
                                                 
1
 It should be noted that developments in critical care of premature babies have in recent years raised numerous 
ethical questions around how decisions should be made about which (if any) premature babies doctors and parents 
should ‘let die’, not least because of concerns about the future health-related quality of life of the child if the baby is 
kept alive (Nuffield Council 2006; Svendsen 2014; see also Heinsen, this volume).    
2
 As Strathern has highlighted there has been concern about the selective potentials of reproductive technologies 
from the very beginning as she showed how the authors of the Glover Report on Reproductive Technologies to the 
European Commission from 1989 suggested that in the future ‘gene therapy and embryo research… will enable us to 
influence the kinds of people who are born’ (Strathern 1992: 31).  
